Principal Investigator
Maria Carpintero
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230934
Clinical Trial Summary
NOVARTIS-CVAY736K12301A randomized, double-blind, parallel group, placebo controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in participants with active lupus nephritis (SIRIUS-LN)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu